Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 1/20 | 0.44 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
| ▸ | PPARA | Q07869 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.40 |
| ▸ | FABP7 | O15540 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | CASP3 | P42574 | 1/20 | 0.37 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5577090 | 1.00 | ITGB3 (0.44) | ITGB3ITGA2BEPHX2PPARGPPARA | |
| SCHEMBL28012104 | 0.94 | ITGB3 (0.43) | ITGB3ITGA2BEPHX2PPARGPPARA | |
| SCHEMBL15632804 | 0.94 | ITGB3 (0.43) | ITGB3ITGA2BEPHX2PPARGPPARA | |
| SCHEMBL29633817 | 0.93 | ITGB3 (0.45) | ITGB3ITGA2BEPHX2PPARGPPARA | |
| SCHEMBL29398902 | 0.93 | ITGB3 (0.45) | ITGB3ITGA2BEPHX2PPARGPPARA | |
| SCHEMBL30510296 | 0.93 | ITGB3 (0.45) | ITGB3ITGA2BEPHX2PPARGPPARA | |
| SCHEMBL118926 | 0.93 | ITGB3 (0.45) | ITGB3ITGA2BEPHX2PPARGPPARA | |
| SCHEMBL120595 | 0.93 | ITGB3 (0.45) | ITGB3ITGA2BEPHX2PPARGPPARA | |
| SCHEMBL120592 | 0.93 | ITGB3 (0.45) | ITGB3ITGA2BEPHX2PPARGPPARA | |
| SCHEMBL29400893 | 0.93 | ITGB3 (0.45) | ITGB3ITGA2BEPHX2PPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3647319-B1 | PEPTIDE COMPOUND, APPLICATION THEREOF AND COMPOSITION CONTAINING SAME | XDCEXPLORER SHANGHAI CO LTD (CN) | 2025-04-09 | — | — | EP | disclosed |
| US-12129312-B2 | Peptide compound, application thereof and composition containing same | XDCEXPLORER (SHANGHAI) CO., LTD. (CN) | 2024-10-29 | — | — | US | disclosed |
| US-11612661-B2 | Conotoxin peptide analogs and uses for the treatment of pain and inflammatory conditions | KINETA CHRONIC PAIN, LLC (US) | 2023-03-28 | — | — | US | disclosed |
| CN-109134610-B | Peptide compound, application thereof and composition containing peptide compound | 尚华医药科技(江西)有限公司 | 2022-07-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11612661-B2 | Conotoxin peptide analogs and uses for the treatment of pain and inflammatory conditions | CHRNG, CHRNA9, CHRNA10 | ITGB3 401/4885ITGA2B 268/4885EPHX2 2218/4885 |
| US-12129312-B2 | Peptide compound, application thereof and composition containing same | VIP, NGLY1, FURIN | ITGB3 4612/4885ITGA2B 4738/4885EPHX2 1798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.